PMID- 28567691 OWN - NLM STAT- MEDLINE DCOM- 20180710 LR - 20181113 IS - 1128-045X (Electronic) IS - 1123-6337 (Linking) VI - 21 IP - 5 DP - 2017 May TI - Autologous adipose tissue-derived stem cells for the treatment of complex perianal fistulas not associated with Crohn's disease: a phase II clinical trial for safety and efficacy. PG - 345-353 LID - 10.1007/s10151-017-1630-z [doi] AB - PURPOSE: Injection of adipose tissue-derived stem cells (ASCs) is a novel method for the treatment of complex perianal fistulas. We aimed to evaluate the safety and efficacy of ASCs in the treatment of complex anal fistulas not associated with Crohn's disease. METHODS: A phase II clinical trial was performed comparing two different doses of ASCs (group 1: 1 x 10(7) cells/mL and group 2: 2 x 10(7) cells/mL). Eligible patients were administered an amount of ASCs proportional to the length of the fistula by injection into the submucosal layer surrounding the internal opening and inside of the fistula tract. ASCs at twice the initial concentration were administered if complete closure was not achieved within 8 weeks. The efficacy endpoint was the complete closure of fistulas 8 weeks after injection. Patients demonstrating complete closure at week 8 were subjected to follow-up for 6 months. RESULTS: Fifteen patients were injected with ASCs; thirteen completed the study. Complete closure was observed in 69.2% (9/13) of patients at 8 weeks. Three of five patients in group 1, and six of eight in group 2 displayed complete closure; no significant differences were observed between the groups. Six of nine patients who showed complete closure participated in additional follow-up; five (83.3%) showed persistent response at 6 months. No grade 3 or 4 adverse events (AEs) were observed; observed AEs were not related to ASC treatment. CONCLUSION: ASCs might be a good option for the treatment of complex perianal fistulas are not healed by conventional operative procedures. FAU - Choi, S AU - Choi S AD - Kangwon National University Hospital, 156, Baengnyeong-ro, Chuncheon-si, Gangwon-do, 24289, Republic of Korea. FAU - Ryoo, S-B AU - Ryoo SB AD - Department of Surgery, Seoul National University Hospital, 101, Daehak-ro (28 Yeongeon-dong), Jongro-gu, Seoul, 03082, Republic of Korea. FAU - Park, K J AU - Park KJ AD - Department of Surgery, Seoul National University Hospital, 101, Daehak-ro (28 Yeongeon-dong), Jongro-gu, Seoul, 03082, Republic of Korea. kjparkmd@plaza.snu.ac.kr. FAU - Kim, D-S AU - Kim DS AD - Daehang Hospital, 2151, Nambusunhwan-ro, Seocho-gu, Seoul, 06699, Republic of Korea. FAU - Song, K-H AU - Song KH AD - Daehang Hospital, 2151, Nambusunhwan-ro, Seocho-gu, Seoul, 06699, Republic of Korea. FAU - Kim, K H AU - Kim KH AD - Ewha Womans University Medical Center, 1071, Anyangcheon-ro, Yangcheon-gu, Seoul, 07985, Republic of Korea. FAU - Chung, S S AU - Chung SS AD - Ewha Womans University Medical Center, 1071, Anyangcheon-ro, Yangcheon-gu, Seoul, 07985, Republic of Korea. FAU - Shin, E J AU - Shin EJ AD - Soonchunhyang University Hospital, 170, Jomaru-ro, Bucheon-si, Gyeonggi-do, 14584, Republic of Korea. FAU - Cho, Y B AU - Cho YB AD - Samsung Medical Center, Sungkyunkwan University School of Medicine, 81, Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea. FAU - Oh, S T AU - Oh ST AD - College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. FAU - Kang, W-K AU - Kang WK AD - College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. FAU - Kim, M H AU - Kim MH AD - Anterogen Co., Ltd., 130, Digital-ro, Geumcheon-gu, Seoul, 08589, Republic of Korea. LA - eng PT - Clinical Trial, Phase II PT - Journal Article PT - Randomized Controlled Trial DEP - 20170531 PL - Italy TA - Tech Coloproctol JT - Techniques in coloproctology JID - 9613614 SB - IM MH - Adipocytes/*transplantation MH - Adipose Tissue/*cytology MH - Adult MH - Humans MH - Male MH - Middle Aged MH - Rectal Fistula/etiology/*therapy MH - Stem Cell Transplantation/*methods MH - Treatment Outcome MH - Young Adult OTO - NOTNLM OT - Adipose tissue-derived OT - Autologous OT - Complex OT - Perianal fistula OT - Stem cells EDAT- 2017/06/02 06:00 MHDA- 2018/07/11 06:00 CRDT- 2017/06/02 06:00 PHST- 2016/06/20 00:00 [received] PHST- 2017/04/16 00:00 [accepted] PHST- 2017/06/02 06:00 [pubmed] PHST- 2018/07/11 06:00 [medline] PHST- 2017/06/02 06:00 [entrez] AID - 10.1007/s10151-017-1630-z [pii] AID - 10.1007/s10151-017-1630-z [doi] PST - ppublish SO - Tech Coloproctol. 2017 May;21(5):345-353. doi: 10.1007/s10151-017-1630-z. Epub 2017 May 31.